Ginkgo Bioworks Holdings (DNA): Large owner Canton Barry sold $417,608 worth of shares (41,172 units at $10.14) (SEC Form 4)
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for DNA
Across the 25 sessions after earlier DNA headlines, the stock closed higher 17 times and lower 8 times, with a median move of 3.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | DNA | SPY |
|---|---|---|---|
| Oct 9, 2026 | Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program | +14.6% | +0.6% |
| Oct 8, 2026 | Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop | -1.1% | -0.4% |
| Sep 29, 2026 | Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium | +14.3% | -0.2% |
| Sep 16, 2026 | Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data | +1.0% | -0.4% |
| Sep 10, 2026 | Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines | -0.1% | -0.6% |
| Aug 7, 2026 | Ginkgo Bioworks downgraded by TD Cowen with a new price target | -6.2% | +0.6% |
Earlier insider filings at DNA
- Oct 21, 2026Officer Kelly Jason R sold $463,353 worth of shares (45,682 units at $10.14) (SEC Form 4)
- Oct 7, 2026Officer Coen Steven P. sold $36,045 worth of shares (2,403 units at $15.00) (SEC Form 4)
- Sep 16, 2026Director Henry Christian O sold $35,405 worth of shares (5,000 units at $7.08), decreasing direct ownership by 21% to 19,310 units (SEC Form 4)
- Aug 25, 2026Officer Coen Steven P. converted options into 743 shares and sold $2,302 worth of shares (330 units at $6.98), increasing direct ownership by 0.80% to 51,851 units (SEC Form 4) (tax liability)
- Jul 30, 2026SEC Form 4 filed by Large owner Canton Barry
Quantisnow market dataNYSE
DNA
Ginkgo Bioworks Holdings Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2021
Get push alerts for DNA
Full DNA profile on Quantisnow Follow DNA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time